Common medication errors with GLP-1 therapies: What patients and providers should know

GLP-1 medications are transforming diabetes and obesity care, and their reach is about to expand dramatically. Medication safety experts at ISMP, an ECRI company, have identified common errors and ...

Discharge Dilemma Ambulatory Surgery Centers Face: Your Patient is Ready to Go, but their Ride is Not

Picture this: a patient has finished an outpatient procedure and is ready to go home. But their ride fell through, or they have no one to drive them home. Maybe they live alone and figured they'd c...

Leveraging Artificial Intelligence in Infection Prevention and Control

Article appeared in Healthcare Hygiene Magazine May/June 2026 issue. By:  Hillary Hei, MPH LSSGB CIC FAPIC, Senior Infection Preventionist, ECRI Artificial intelligence (AI) has become a major disr...

ECRI Leaders Named Becker's Patient Safety Experts to Know – Again

For the second consecutive year, ECRI President and CEO Marcus Schabacker, MD, PhD, and Shannon Kooker, Vice President of Clinical Excellence and Patient Safety, have both been named to the Becker...

ECRI’s New U.S. Headquarters and Device Evaluation Lab

Newly Renovated Headquarters & Lab ECRI relocated its U.S. headquarters to a newly renovated facility near Philadelphia, located at 500 Virginia Dr., Suite 501, Fort Washington, PA 19034. ECRI’...

Data analysis by ECRI on patient falls reveals common risk factors

Patient transfers accounted for nearly half of falls events reported to ECRI in a new analysis, underscoring how routine patient movement activities can create major safety vulnerabilities.  The la...

USA Today Features ECRI in Special Edition on Patient Safety

ECRI was featured in a special edition of USA Today, sharing insights on how healthcare leaders can reduce preventable harm and build safer, more reliable systems of care. ECRI President and CEO ...

Patients Using Wellness Peptides Have No Reliable Information About Whether They Are Safe or Effective, ECRI and ISMP Warn

New joint white paper asserts commercial market for compounded peptide products has outpaced the clinical evidence; unless the product is explicitly FDA-approved, there is insufficient evidence of ...

ECRI Research Team Wins National Award for Uncovering Hidden Risks in Disposable Isolation Gowns

Study found that standard liquid barrier tests may underestimate real-world failure risk, raising new questions about how healthcare facilities validate protective apparel A research team at ECRI r...